I have been working with early-stage companies and entrepreneurs for over 20 years as both a business mentor and advisor to innovative start-ups. I am passionate about innovation and helping entrepreneurs to achieve success; my knowledge and perspective on fundraising and investment trends help businesses prepare to raise external funding. With strong links across the early-stage equity landscape I believe collaboration is vital to ensure innovation thrives.

25 years experience working with pharmaceutical, biotech, scientific instrument companies, and has held positions in marketing, business insights, product and project development. Currently he works to help seed and Series A stage companies to commercialise towards exit or market and obtain investment. These business development partnerships are typically very collaborative. Areas include the development of business strategy and tactics, investment, priorities for platform science and technology, route to market planning, instigating partnerships and specific projects such as grant applications. He has made 15+ angel investments and 45+ listed company investments in UK and international life science and impact companies. Works as a pro-bono mentor for accelerators.

"Josh is a Partner at Osney Capital, a value-add Venture Capital fund that invests in start-up and growth businesses in the Enterprise Technology sector, whilst supporting them to navigate their operational complexity as it evolves with their scale.

Josh has a background in Cyber Security and Financial Services, in Strategy, Growth and Front Office roles. Josh has an engineering degree from the University of Birmingham and an MBA from the University of Oxford."

An experienced Executive Director, Public Speaker, Consultant and Business Mentor, across multiple industries. Previous experience includes roles as CEO and Founder of an Oxford University Spin-out, Business Development Consultant, National Quality Manager, Material planner and Global Project Co-Ordinator.
With a demonstrated history of working in the Deep Tech, Sports Tech, Software Development, Business Consulting, Manufacturing, Automotive and Steel industries, within Australia, UK, Asia, and the US.
Core attributes are an entrepreneurial mindset with strong communication and leadership skills, and significant experience in strategic planning, early-stage venture capital fund raising, business process thinking, corporate governance and change management.

"I connect early-stage pharma R&D candidates with partners and other supporters.
I'm the CEO of Probatech, a consultancy founded to make sure that new healthcare products are developed to their full potential.

Over a varied career, I've found it unsettling that the world’s healthcare needs aren't met because potential solutions have been overlooked. Sometimes it's due to a lack of knowledge, sometimes a lack of resources.
But I believe it doesn't have to be this way and I'm now dedicated to helping startups and university teams drive their new drugs and vaccines to the next milestone before running out of time.

Having worked in pharmacy, in drug discovery research and as a consultant, I've gained a unique perspective on the challenges of bringing healthcare products to market. I've collaborated with biotech startups, Fortune 100 pharma companies and academic labs all over the world, and that's given me a better idea of the big picture.

Over the last 7 years, I’ve helped numerous life science organisations to understand how to get to their next developmental or commercial milestone without wasting time or money. Together with my team at Probatech, I'm using this experience to make vital connections between knowledge, people and resources to fast-track new healthcare products to the clinic.

Whether you're a startup with an exciting pipeline, or a larger organisation looking to support new ideas, please feel free to drop me a message.
I'd also love to hear from anyone who shares a passion for healthcare innovation, ecosystems and entrepreneurship in general."

Parkwalk Advisors invest in scientifically driven early stage companies in the UK. Emilie joined Parkwalk from Oxford University Innovation, where she worked both in the Investments Team and leading the Startup Incubator, managing over 80 projects and companies from inception to exit. She moved into technology transfer after 14 years as a research scientist, directing pioneering experiments in systems neuroscience in Oxford, Bordeaux and Hamburg. Emilie holds a PhD in Neuroscience from the University of Hamburg and an MBA from Warwick Business School, specialising in Strategy and Finance.

Paul has over 15 years of experience as a financial services and regulatory lawyer, including eight years as a partner leading the corporate team at offshore law firm Collas Crill LLP, building and nurturing high-performing teams. He built a diverse practice including advising on venture capital fund and joint venture structuring, mergers and acquisitions, banking & finance and financial services regulation. Paul has a MBA from the University of Oxford, an LLB from the University of New South Wales and a first class honours degree in Physiotherapy from Sydney University. Paul is currently working towards the first close of a venture capital firm he has founded with two fellow Oxonians.

Holding a degree in Quality Control of Medicines from the Federico II University of Naples and an MBA from Business School Lausanne, Valentina is a motivated and ambitious professional that has 13 years' experience in the pharma industry. Valentina has spent most of her career in Novartis in roles of increasing responsibility within quality assurance and manufacturing areas of drug development and commercial business units. After her MBA she decided to joined several “start-up like” companies. Now focused on driving and leading quality for a growing international cosmetic brand. She is positive, creative and inspiring with the passion for continuous improvement and problem solving. Traveler. Painter. Art and books lover.

"As a Chartered (UK) and European Patent Attorney, Matthew advises a wide range of clients in high tech fields, with particular expertise in computing and medical devices. He has been active in protecting innovations within the fields of medical devices, machine learning, digital healthcare and telecommunications. Matthew is also a Registered European Design Attorney, with experience advising clients on filing design registrations in the UK and Europe.

Matthew has been an active supporter of the ImagineIF! competition, acting as a mentor and advisor to applicants since 2016. "

David has a background in biochemistry, immunology and molecular biology with a PhD from Imperial College, London and three years of post-doctoral experience. David has worked in the pharmaceutical industry for over 20 years. He worked in big pharma at AstraZeneca for more than 17 years in a wide variety of R&D roles both in the UK and the US. Whilst at AstraZeneca he was heavily involved in developing the use of informatics and systems biology to support the development of new medicines. David joined Blueberry Therapeutics as Chief Scientific Officer at the start of 2014. In this role, he is responsible for leading the research activities of the business which are focused on developing new treatments for serious infectious diseases. The first of these treatments is currently in Phase 2 clinical testing.